JWBK208-02 December 8, 2007 21:25 Char Count= 0
Histotechniques 15
±ve:cervical SCC, gastric carcinoma, colonic adenocarcinoma (85% are −ve), cholangiocarci-
noma, some NE tumours, SmCC, epithelioid haemangioendothelioma, prostatic carcinoma,
RCC (chromophobe > papillary > conventional)
r
CK20:
+ve:Merkel cell
CA, colorectal CA, pancreatic CA, gallbladder CA, TCC, breast papillary tumours,
mucinous tumours (breast, colorectum, ovary), endocrine and NE cells, normal gastroin-
testinal epithelium, some salivary gland SmCC (but not other 1
◦
sites)
−ve:SmCC (except of salivary gland), SCC, RCC, prostatic
CA, mesothelium, normal breast /
sweat / salivary glands, biliary and pancreatic ducts, alveoli, renal collecting duct cells
±ve: pulmonary adenocarcinoma, breast IDC of NST
r
34E12 is said to be one of the best markers for squamous differentiation in poorly diff SCC. TCC is
±ve (more likely to be +ve if heat Ag retrieval is used cf. enzyme digestion). PTC is +ve cf. hyalinising
trabecular tumour (−ve).
r
CK8 and CK18 (CAM5.2) stains hepatocytes and wide variety of simple epithelia (incl. biliary ep-
ithelium) and some non-epithelial tissues e.g. LN reticulum cells, subserosal cells, ALCL, myeloma,
melanoma, Schwannoma, muscle tumours, angiosarcoma., MFH, meningioma
r
CK7 and CK19 stain biliary epithelium but usu. not hepatocytes. CK19 stains 10% of HCC, 50%
of cholangiocarcinoma, 15% of carcinoma metastatic to the liver, many simple epithelia, dermal
basal cells, mesothelium, PTC (strong diffuse +vity) cf. follicular thyroid lesions (focal +/ pe-
ripheral +vity) incl. hyalinising trabecular tumour (usu. −ve) but >50% of benign thyroids are
+ve.
r
CK5/6 stains prostatic basal cells; for ADH see p. 258; 1
◦
pulmonary adenocarcinoma are usu. −ve
but SCC +ve; mesothelioma +ve; mesothelial cells +ve (e.g. in LN inclusions), TCC ±ve
Immunostaining melanotic lesions
r
Use of Azure B as counterstain (instead of haematoxylin) turns melanin cyan leaving DAB as brown
r
Peroxidase-based Ab systems may also be developed with alternative chromogens such as 3-amino-
9-ethylcarbazole (AEC – red but carcinogenic) or 4-chloro-1-naphthol (dark blue). These are both
soluble in alcohol so the sections need to be counterstained with (e.g.) methyl green, air-dried and
aqueous-mounted. These are also 10 to 20 times less sensitive detection methods cf. DAB
r
ALP-based Ab systems (if available) may be developed with ‘Fast Blue BB’ or ‘Fast Red’
r
Bleaching the melanin before immunostaining can alter the antigenicity of many Ags
S100 protein (Dimers of α and β subunits)
Positive normal structures
r
Present in ≈ all cells (and may stain all cells if unfixed tissue is used); nuclear +/ cytoplasmic staining
r
Schwann, perineural and myoepithelial cells, glia, melanocytes, (some neurons are -subunit +ve)
r
-subunit +ve in IDC and Langerhans cells; -subunit +ve in M (e.g. in LN tingible bodies / sinuses)
r
Cartilage, skeletal muscle, adipocytes, mast cells; sparse spindle cells in healing wounds
r
Folliculostellate cells (anterior pituitary), posterior pituicytes (-subunit), paraganglial sustentacular
cells, fetal adrenal neuroblasts (but not phaeochromocytes), thyroid follicular cells (±ve)
r
Some Leydig, Sertoli and granulosa cells
r
Some ductal epithelial cells in the breast, salivary glands and sweat glands
r
Some acinar epithelial cells in sweat glands and peribronchial serous glands
Some positive pathological lesions (there are many more than those listed here)
r
Melanoma (! small cell variant can be −ve), oligodendroglioma (often GFAP −ve), astrocytomas, NB
r
Histiocytosis X (CD1a +ve), Rosai-Dorfman disease (CD1a −ve), IDC sarcoma
r
soft tissue tumours: Schwannoma (incl. granular cell tumour), MPNST, CCSTA, liposarcoma / lipomas,
chordoma, chondroma, chondrosarcoma and some synovial sarcoma and alveolar soft part sarcomas
r
Some Leydig, Sertoli and granulosa cell tumours; ovarian carcinomas and FATWO
r
Microglandular adenosis of the breast (epithelial cells) but not tubular carcinoma
r
50% of invasive carcinoma and Paget’s disease of the breast and ≈all phyllodes (epithelial component)
r
Salivary gland carcinomas: PLGA, salivary duct carcinoma, signet ring carcinoma, AdCC
r
30% of Merkel cell carcinomas show +vity of variable extent
r
Many thyroid carcinomas (follicular, papillary and medullary) – -subunit more commonly than
HMB45 (gp100)
r
Some melanomas (desmoplastic ones are often −ve esp. in deep spindle cells, but S100 is usu. +ve),
Spitz naevi, DPN and all blue naevi (benign or malignant) (for more details, see Chapter 20: Skin)
r
Benign junctional melanocytes/nests and anal melanocytes in squamous and transitional zones
r
Atypical/congenital/hormonal naevi can be +ve but other typical benign naevocytes are −ve